Claret Asset Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$293K Sell
318
-1
-0.3% -$1.01K 0.04% 195
2025
Q4
$343K Sell
319
-121
-28% -$116K 0.04% 149
2025
Q3
$336K Hold
440
0.04% 141
2025
Q2
$343K Sell
440
-7
-2% -$5.44K 0.04% 124
2025
Q1
$369K Buy
447
+21
+5% +$17.5K 0.05% 126
2024
Q4
$329K Buy
426
+2
+0.5% +$1.66K 0.05% 120
2024
Q3
$376K Hold
424
0.06% 103
2024
Q2
$384K Sell
424
-70
-14% -$56K 0.07% 98
2024
Q1
$384K Hold
494
0.06% 105
2023
Q4
$288K Buy
494
+16
+3% +$9.34K 0.05% 114
2023
Q3
$257K Sell
478
-16
-3% -$8.24K 0.05% 116
2023
Q2
$232K Buy
+494
New +$207K 0.05% 128
2020
Q1
Sell
-29,675
Closed -$3.9M 186
2019
Q4
$3.9M Buy
29,675
+1,145
+4% +$133K 0.75% 35
2019
Q3
$3.19M Sell
28,530
-85
-0.3% -$9.46K 0.66% 43
2019
Q2
$3.17M Sell
28,615
-655
-2% -$77.1K 0.66% 45
2019
Q1
$3.8M Sell
29,270
-400
-1% -$48.6K 0.76% 43
2018
Q4
$3.43M Sell
29,670
-1,138
-4% -$127K 0.76% 45
2018
Q3
$3.31M Sell
30,808
-360
-1% -$36K 0.64% 48
2018
Q2
$2.66M Buy
31,168
+790
+3% +$64.9K 0.54% 51
2018
Q1
$2.35M Sell
30,378
-60
-0.2% -$4.83K 0.53% 52
2017
Q4
$2.57M Buy
+30,438
New +$2.59M 0.56% 50

Other funds holding LLY

Claret Asset Management's LLY Position: Q1 2026 in Review

Claret Asset Management reduced its Eli Lilly (LLY) stake by 0.31% in Q1 2026, selling an estimated $1.01K and leaving 318 shares worth $293K. The position accounts for 0.04% of the portfolio, ranked #195.

Claret Asset Management first reported a position in LLY in Q4 2017 and has held it in 21 quarters since. The position peaked at $3.9M in Q4 2019. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Claret Asset Management held 318 shares of Eli Lilly worth $293K as of Q1 2026.
  • Claret Asset Management sold 1 Eli Lilly share in Q1 2026, an estimated $1.01K.
  • Eli Lilly made up 0.04% of Claret Asset Management's portfolio in Q1 2026, its #195 holding.
  • Claret Asset Management first reported a position in Eli Lilly in Q4 2017 and has held it in 21 quarters since.
  • Claret Asset Management's Eli Lilly position peaked at $3.9M in Q4 2019.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Claret Asset Management's 13F filing for Q1 2026, filed 11 May 2026.